ADPT (STOCKS)
Adaptive Biotechnologies Corporation Common Stock
$14.010000
-0.520000 (-3.58%)
Prev close: $14.530000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Chad Robins
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,235.82M
- Employees
- 619
- P/E (TTM)
- -36.44
- P/B (TTM)
- 10.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.09 | $-0.18 | +0.0949 | +51.33% |
|
Sep 2025 (Q3)
|
$0.06 | $-0.15 | +0.2092 | +140.21% |
|
Jun 2025 (Q2)
|
$-0.17 | $-0.24 | +0.0735 | +30.18% |
|
Mar 2025 (Q1)
|
$-0.20 | $-0.30 | +0.0984 | +32.98% |
Financial Statements
| Revenues | $403.74M |
| Benefits Costs and Expenses | $211.74M |
| Costs And Expenses | $211.74M |
| Nonoperating Income/Loss | $172.73M |
| Operating Expenses | $379.83M |
| Operating Income/Loss | $20.39M |
| Income/Loss Before Equity Method Investments | $195.18M |
| Income/Loss From Continuing Operations After Tax | $146.38M |
| Income/Loss From Continuing Operations Before Tax | $192.00M |
| Income/Loss From Equity Method Investments | -$2.06M |
| Income Tax Expense/Benefit | $46.74M |
| Income Tax Expense/Benefit, Deferred | $45.69M |
| Interest Expense, Operating | $7.51M |
| Net Income/Loss | $146.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | $61.68M |
| Net Income/Loss Attributable To Parent | $84.70M |
| Net Income/Loss Available To Common Stockholders, Basic | $84.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $798.68M |
| Current Assets | $169.09M |
| Noncurrent Assets | $629.59M |
| Fixed Assets | $33.73M |
| Intangible Assets | $16.90M |
| Other Non-current Assets | $578.96M |
| Liabilities | $453.48M |
| Current Liabilities | $59.07M |
| Wages | $19.84M |
| Other Current Liabilities | $39.23M |
| Noncurrent Liabilities | $394.41M |
| Equity | $345.20M |
| Equity Attributable To Noncontrolling Interest | $85.08M |
| Equity Attributable To Parent | $260.12M |
| Liabilities And Equity | $798.68M |
| Net Cash Flow From Operating Activities | -$29.32M |
| Net Cash Flow From Operating Activities, Continuing | -$29.32M |
| Net Cash Flow From Investing Activities | -$9.31M |
| Net Cash Flow From Investing Activities, Continuing | -$9.31M |
| Net Cash Flow From Financing Activities | -$1.60M |
| Net Cash Flow From Financing Activities, Continuing | -$1.60M |
| Net Cash Flow | -$40.23M |
| Net Cash Flow, Continuing | -$40.23M |
| Comprehensive Income/Loss | $146.38M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $60.94M |
| Comprehensive Income/Loss Attributable To Parent | $85.44M |
| Other Comprehensive Income/Loss | $0.00 |